Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions with Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels

Biological Psychiatry
Nao J GamoAmy F T Arnsten

Abstract

Psychiatric disorders such as schizophrenia are worsened by stress, and working memory deficits are often a central feature of illness. Working memory is mediated by the persistent firing of prefrontal cortical (PFC) pyramidal neurons. Stress impairs working memory via high levels of dopamine D1 receptor (D1R) activation of cyclic adenosine monophosphate signaling, which reduces PFC neuronal firing. The current study examined whether D1R-cyclic adenosine monophosphate signaling reduces neuronal firing and impairs working memory by increasing the open state of hyperpolarization-activated cyclic nucleotide-gated (HCN) cation channels, which are concentrated on dendritic spines where PFC pyramidal neurons interconnect. A variety of methods were employed to test this hypothesis: dual immunoelectron microscopy localized D1R and HCN channels, in vitro recordings tested for D1R actions on HCN channel current, while recordings in monkeys performing a working memory task tested for D1R-HCN channel interactions in vivo. Finally, cognitive assessments following intra-PFC infusions of drugs examined D1R-HCN channel interactions on working memory performance. Immunoelectron microscopy confirmed D1R co-localization with HCN channels near exc...Continue Reading

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P K DashE R Kandel
Sep 1, 1987·Archives of Gerontology and Geriatrics·P S Goldman-Rakic
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C CepedaM S Levine
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·F A WilsonP S Goldman-Rakic
Aug 14, 1995·The Journal of Comparative Neurology·M F Kritzer, P S Goldman-Rakic
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·B L MurphyR H Roth
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M BaradE Kandel
Jan 3, 2001·The Journal of Biological Chemistry·C Ulens, J Tytgat
Dec 14, 2001·The Journal of Biological Chemistry·Catherine ProenzaEric A Accili
Jun 25, 2002·Trends in Neurosciences·Verity J Brown, Eric M Bowman
Jul 16, 2002·Nature Neuroscience·Nicholas P PoolosDaniel Johnston
Dec 10, 2002·Annual Review of Physiology·Richard B Robinson, Steven A Siegelbaum
Aug 23, 2003·Behavioral Neuroscience·Mark R StefaniBita Moghaddam
Oct 22, 2003·Molecular Psychiatry·R M ShanskyA F T Arnsten
Dec 4, 2003·Behavioural Brain Research·Harry B M UylingsBryan Kolb
Jan 31, 2004·The Journal of Biological Chemistry·Vincenzo Macri, Eric A Accili
Feb 6, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lin PeiFang Liu
Feb 7, 2004·Science·Min WangPatricia S Goldman-Rakic
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Guojun ChenZhen Yan
Mar 3, 2004·The Journal of Comparative Neurology·Takuya Notomi, Ryuichi Shigemoto
Aug 5, 2005·The Journal of Biological Chemistry·Xiangang ZongMartin Biel
Sep 24, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michelle DayD James Surmeier
Feb 1, 2006·The Journal of General Physiology·Catherine Proenza, Gary Yellen
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alessandro BertolinoBruno Dallapiccola
May 9, 2006·Journal of Cardiovascular Pharmacology·Suzanne S ArinsburgHan-Gang Yu
Oct 3, 2006·The American Journal of Psychiatry·Jussi HirvonenJarmo Hietala
Feb 6, 2007·Nature Neuroscience·Susheel VijayraghavanAmy F T Arnsten
Sep 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David A Lewis, Guillermo González-Burgos
Jun 27, 2008·American Journal of Physiology. Cell Physiology·Sriharsha VemanaH Peter Larsson
Dec 17, 2008·Neurotoxicity Research·Jeremy K SeamansDaniel Durstewitz
May 21, 2009·Nature Reviews. Neuroscience·Amy F T Arnsten
Jun 18, 2010·Trends in Cognitive Sciences·Amy F T ArnstenMin Wang
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nikolai C DembrowDaniel Johnston

❮ Previous
Next ❯

Citations

Jan 31, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Veronica BisagnoFrancisco J Urbano
Jan 8, 2016·Annual Review of Pharmacology and Toxicology·Amy F T Arnsten, Min Wang
Oct 22, 2016·Frontiers in Psychiatry·Nicole Mons, Daniel Beracochea
May 17, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Anne M LandauDoris J Doudet
Jun 1, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stacy M Ku, Ming-Hu Han
Jun 24, 2017·Psychological Medicine·O T OusdalR J Dolan
Feb 22, 2018·Reviews in the Neurosciences·Diego GuidolinLuigi F Agnati
Sep 15, 2018·Behavioural Pharmacology·Zahra BahariMohammad A Meftahi
Jul 8, 2016·Science Advances·Joshua L RoffmanCiprian Catana
Jun 25, 2015·Pharmacological Reviews·Amy F T ArnstenConstantinos D Paspalas
Jun 27, 2019·Scientific Reports·Yoann LussierNazzareno D'Avanzo
Jan 27, 2019·Scientific Reports·Jérémie TanguayNazzareno D'Avanzo
Sep 26, 2015·Nature Neuroscience·Amy F T Arnsten
Jan 11, 2020·Frontiers in Systems Neuroscience·Nathalie AndréRoy F Baumeister
Sep 26, 2015·Nature Neuroscience·Nick G HollonPaul E M Phillips
Oct 11, 2017·The International Journal of Neuropsychopharmacology·Eunice Y YuenZhen Yan
Mar 6, 2019·Frontiers in Endocrinology·Diego GuidolinLuigi F Agnati
Dec 16, 2020·Molecular Psychiatry·Amy F T ArnstenMin Wang
Jun 22, 2021·Frontiers in Molecular Neuroscience·Deepanjali Dwivedi, Upinder S Bhalla
Jul 22, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jason SmucnyCameron S Carter
Jul 28, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Roshan Cools, Amy F T Arnsten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here